Identification of transcriptomic determinants to predict the efficacy of anti-EGFR treatment of colorectal cancer patients.

被引：0
|
作者：
Chowdhury, Saikat [1 ]
Shen, John Paul Y. C. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期
关键词：
D O I：
10.1200/JCO.2021.39.3_suppl.130
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
130
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer
    Woolston, Andrew
    Khan, Khurum
    Spain, Georgia
    Barber, Louise J.
    Griffiths, Beatrice
    Gonzalez-Exposito, Reyes
    Hornsteiner, Lisa
    Punta, Marco
    Patil, Yatish
    Newey, Alice
    Mansukhani, Sonia
    Davies, Matthew N.
    Furness, Andrew
    Sclafani, Francesco
    Peckitt, Clare
    Jimenez, Mirta
    Kouvelakis, Kyriakos
    Ranftl, Romana
    Begum, Ruwaida
    Rana, Isma
    Thomas, Janet
    Bryant, Annette
    Quezada, Sergio
    Wotherspoon, Andrew
    Khan, Nasir
    Fotiadis, Nikolaos
    Marafioti, Teresa
    Powles, Thomas
    Lise, Stefano
    Calvo, Fernando
    Guettler, Sebastian
    von Loga, Katharina
    Rao, Sheela
    Watkins, David
    Starling, Naureen
    Chau, Ian
    Sadanandam, Anguraj
    Cunningham, David
    Gerlinger, Marco
    CANCER CELL, 2019, 36 (01) : 35 - +
  • [2] Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients
    Ruzzo, A.
    Graziano, F.
    Canestrari, E.
    Magnani, M.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (01) : 68 - 79
  • [3] Anti-EGFR monoclonal antibody treatment in colorectal cancer
    Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 (6): : 249 - 250
  • [4] Optimization of Anti-EGFR Treatment of Advanced Colorectal Cancer
    Vecchione, Loredana
    CURRENT COLORECTAL CANCER REPORTS, 2014, 10 (03) : 263 - 271
  • [5] Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer
    F Di Fiore
    R Sesboüé
    P Michel
    J C Sabourin
    T Frebourg
    British Journal of Cancer, 2010, 103 : 1765 - 1772
  • [6] Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer
    Di Fiore, F.
    Sesbouee, R.
    Michel, P.
    Sabourin, J. C.
    Frebourg, T.
    BRITISH JOURNAL OF CANCER, 2010, 103 (12) : 1765 - 1772
  • [7] An Update on the Role of Anti-EGFR in the Treatment of Older Patients with Metastatic Colorectal Cancer
    Rosati, Gerardo
    Montrone, Michele
    Pacilio, Carmen
    Colombo, Alfredo
    Cicero, Giuseppe
    Paragliola, Fernando
    Vaia, Angelo
    Annunziata, Luigi
    Bilancia, Domenico
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [8] Changes in the efficacy of anti-EGFR antibody drugs by exosomes derived from colorectal cancer patients
    Morimura, Rii
    Tsukamoto, Kei
    Irie, Shinji
    Kitano, Shiro
    Shinozaki, Eiji
    Yamaguchi, Kensei
    CANCER RESEARCH, 2018, 78 (13)
  • [9] DNA methylation profile to predict clinical outcome of anti-EGFR treatment in metastatic colorectal cancer.
    Ouchi, Kota
    Takahashi, Shin
    Yamada, Yasuhide
    Tsuji, Shingo
    Tatsuno, Kenji
    Takahashi, Hidekazu
    Takahashi, Naoki
    Takahashi, Masanobu
    Shimodaira, Hideki
    Aburatani, Hiroyuki
    Ishioka, Chikashi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Blood-based molecular detection of acquired resistance to anti-EGFR therapies in colorectal cancer patients.
    Siravegna, Giulia
    Bianchi, Andrea Sartore
    Cassingena, Andrea
    Bencardino, Katia
    Diaz, Luis A.
    Sausen, Mark
    Velculescu, Victor E.
    Di Nicolantonio, Federica
    Siena, Salvatore
    Bardelli, Alberto
    CANCER RESEARCH, 2013, 73 (08)
12345